CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Gate Neurosciences, Inc

For profitWebsite ↗

Also known as: Gate Neurosciences, Inc | Ronald M Burch MD PhD | Syndeio Biosciences, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 30, 2025

Timeline

2010s

Jun 1, 2018
Gate Neurosciences, Inc— Founded

Drugs by trial phase (3 distinct, 7 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

gate-101

Indications

Studied for

Recent trials (12)

NCT07115329Lead sponsorPhase 2Nov 30, 2025
NCT07099989OfficialPhase 1Jul 24, 2025
NCT07099989Lead sponsorPhase 1Jul 24, 2025
NCT06400121CollaboratorPhase 2Oct 28, 2024
NCT06547489Lead sponsorPhase 2Sep 30, 2024
NCT05597241Overall official - principal investigatorPhase 1Oct 15, 2022
NCT05597241Lead sponsorPhase 1Oct 15, 2022
NCT04618263Lead sponsorPhase 1Oct 26, 2020
NCT04618263Study directorPhase 1Oct 26, 2020
NCT04981561Study directorPhase 1Dec 9, 2016
NCT04981561Lead sponsorPhase 1Dec 9, 2016
NCT04981561Sponsor investigatorPhase 1Dec 9, 2016

Details

Founded: Carmel, IN, US Jun 1, 2018
Last known activity: Nov 30, 2025